Young F. James's most recent trade in Novavax, Inc. was a trade of 5,400 Common Stock done at an average price of $8 . Disclosure was reported to the exchange on Dec. 24, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Novavax, Inc. | Young F. James | Director | 24 Dec 2024 | 5,400 | 51,760 (0%) | 0% | 8 | 43,200 | Common Stock | |
| Novavax, Inc. | James Young F. | Director | 24 Dec 2024 | 4,600 | 57,160 (0%) | 0% | 8.5 | 39,008 | Common Stock | |
| Novavax, Inc. | James F. Young | Director | 21 Jun 2024 | 7,500 | 61,760 (0%) | 0% | 14.1 | 105,675 | Common Stock | |
| Novavax, Inc. | James F. Young | Director | 18 Jun 2024 | 6,393 | 70,367 (0%) | 0% | 13.6 | 87,073 | Common Stock | |
| Novavax, Inc. | James F. Young | Director | 18 Jun 2024 | 1,107 | 69,260 (0%) | 0% | 14.3 | 15,808 | Common Stock | |
| Novavax, Inc. | James F. Young | Director | 12 Jun 2024 | 15,630 | 15,630 | - | - | Stock Option (Right to Buy) | ||
| Novavax, Inc. | James F. Young | Director | 12 Jun 2024 | 10,420 | 10,420 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | James F. Young | Director | 12 Jun 2024 | 6,670 | 76,760 (0%) | 0% | 0 | Common Stock | ||
| Novavax, Inc. | James F. Young | Director | 12 Jun 2024 | 6,670 | 0 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | James F. Young | Director | 10 Jun 2023 | 7,710 | 7,710 | - | - | Stock Option (Right to Buy) | ||
| Novavax, Inc. | James F. Young | Director | 10 Jun 2023 | 6,670 | 6,670 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | James F. Young | Director | 10 Jun 2023 | 4,600 | 68,590 (0%) | 0% | - | Common Stock | ||
| Novavax, Inc. | James F. Young | Director | 10 Jun 2023 | 4,600 | 0 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | James F. Young | Director | 17 Jun 2022 | 1,400 | 63,990 (0%) | 0% | - | Common Stock | ||
| Novavax, Inc. | James F. Young | Director | 17 Jun 2022 | 1,400 | 0 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | James F. Young | Director | 10 Jun 2022 | 6,900 | 6,900 | - | - | Stock Option (Right to Buy) | ||
| Novavax, Inc. | James F. Young | Director | 10 Jun 2022 | 4,600 | 4,600 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | James F. Young | Director | 31 Mar 2022 | 8,945 | 66,145 (0%) | 0% | 73.3 | 655,550 | Common Stock | |
| Novavax, Inc. | James F. Young | Director | 31 Mar 2022 | 3,255 | 62,890 (0%) | 0% | 74.3 | 241,684 | Common Stock | |
| Novavax, Inc. | James F. Young | Director | 31 Mar 2022 | 300 | 62,590 (0%) | 0% | 75.1 | 22,531 | Common Stock | |
| Novavax, Inc. | James F. Young | Director | 01 Jul 2021 | 10,000 | 75,090 (0%) | 0% | - | Common Stock | ||
| Novavax, Inc. | James F. Young | Director | 01 Jul 2021 | 10,000 | 0 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | James F. Young | Director | 25 Jun 2021 | 7,590 | 65,090 (0%) | 0% | - | Common Stock | ||
| Novavax, Inc. | James F. Young | Director | 25 Jun 2021 | 7,590 | 0 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | James F. Young | Director | 17 Jun 2021 | 2,600 | 2,600 | - | - | Stock Option (Right to Buy) | ||
| Novavax, Inc. | James F. Young | Director | 17 Jun 2021 | 1,400 | 1,400 | - | - | Restricted Stock Units | ||
| Novavax, Inc. | James F. Young | Director | 23 Mar 2021 | 37,500 | 0 | - | - | Stock Option (Right to Buy) | ||
| Novavax, Inc. | James F. Young | Director | 23 Mar 2021 | 37,500 | 57,500 (0%) | 0% | 4.0 | 149,438 | Common Stock | |
| Novavax, Inc. | James F. Young | Director | 23 Mar 2021 | 10,000 | 20,000 (0%) | 0% | 46 | 460,000 | Common Stock | |
| Novavax, Inc. | James F. Young | Director | 23 Mar 2021 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | ||
| Novavax, Inc. | James F. Young | Director | 23 Mar 2021 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | ||
| Novavax, Inc. | James F. Young | Director | 23 Mar 2021 | 10,000 | 20,000 (0%) | 0% | 27.6 | 276,000 | Common Stock | |
| Novavax, Inc. | James F. Young | Director | 23 Mar 2021 | 4,434 | 15,566 (0%) | 0% | 227.4 | 1,008,435 | Common Stock | |
| Novavax, Inc. | James F. Young | Director | 23 Mar 2021 | 3,120 | 12,446 (0%) | 0% | 228.4 | 712,661 | Common Stock | |
| Novavax, Inc. | James F. Young | Director | 23 Mar 2021 | 2,446 | 10,000 (0%) | 0% | 229.4 | 561,134 | Common Stock | |
| Novavax, Inc. | James F. Young | Director | 05 Dec 2020 | 20,000 | 20,000 | - | - | Restricted Stock Units |